NEW DelHI, Juni 22 (Xinhua) - Wopanga katemera waku India wa Bharat Biotech Covaxin wawonetsa mphamvu 77.8% pamayesero a gawo lachitatu, atolankhani angapo akumaloko adanenanso Lachiwiri.
"Bharat Biotech's Covaxin ndi 77.8% yothandiza poteteza ku COVID-19, malinga ndi kafukufuku wa gawo lachitatu lomwe adachita nawo 25,800 ku India," lipotilo lidatero.
Chiwopsezo chogwira ntchito chidatuluka Lachiwiri pambuyo poti komiti ya akatswiri a mankhwala a Drug Controller General of India (DCGI) (SEC) idakumana ndikukambirana zotsatira.
Kampani yopanga mankhwala idapereka gawo lachitatu la mayeso a katemera ku DCGI kumapeto kwa sabata.
Malipoti ati kampaniyo ikuyembekezeka kuchita msonkhano wa "pre-submit" ndi akuluakulu a World Health Organisation Lachitatu, kuti akambirane malangizo omwe angaperekedwe komaliza kwa zikalata zofunika.
India idayamba kulandira katemera wa COVID-19 pa Januware 16 popereka katemera awiri opangidwa ku India, omwe ndi Covishield ndi Covaxin.
Serum Institute of India (SII) ikupanga Covishield ya AstraZeneca-Oxford University, pomwe Bharat Biotech idagwirizana ndi Indian Council of Medical Research (ICMR) popanga Covaxin.
Katemera waku Russia wa Sputnik V adatulutsidwanso mdziko muno.Enditem
Nthawi yotumiza: Jun-25-2021